Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik S Blomain

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta|July 7, 2012
Dynamic regulation of mitochondrial transcription as a mechanism of cellular adaptationErik S Blomain, Steven B McMahon
International Journal of Molecular Sciences|October 23, 2021
Liquid Biopsies for Molecular Biology-Based RadiotherapyErik S Blomain, Everett J Moding
Cancer Biology & Therapy|April 23, 2016
GUCY2C ligand replacement to prevent colorectal cancerErik S Blomain, Amanda M Pattison, Scott A Waldman
Pigment Cell & Melanoma Research|March 16, 2013
Selective RAF inhibitor impairs ERK1/2 phosphorylation and growth in mutant NRAS, vemurafenib-resistant melanoma cellsKaitlyn Le, Erik S Blomain, Ulrich Rodeck, et al.
Expert Opinion on Drug Discovery|April 30, 2013
New advances in models and strategies for developing anti-obesity drugsGilbert W Kim, Jieru E Lin, Erik S Blomain, et al.
World Journal of Gastroenterology|October 1, 2016
Guanylyl cyclase C signaling axis and colon cancer preventionAmanda M Pattison, Dante J Merlino, Erik S Blomain, et al.
Journal of Clinical Medicine|August 4, 2015
Gut-Brain Endocrine Axes in Weight Regulation and Obesity PharmacotherapyDante J Merlino, Erik S Blomain, Amanda S Aing, et al.
Practical Radiation Oncology|August 16, 2020
A Preliminary Report of Gonadal-Sparing TBI Using a VMAT TechniqueErik S Blomain, Nataliya Kovalchuk, Beth K Neilsen, et al.
Molecular Pharmacology|June 3, 2016
Guanylyl Cyclase C Hormone Axis at the Intersection of Obesity and Colorectal CancerErik S Blomain, Dante J Merlino, Amanda M Pattison, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2CMatthew Witek, Erik S Blomain, Michael S Magee, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta|July 7, 2012
Dynamic regulation of mitochondrial transcription as a mechanism of cellular adaptationErik S Blomain, Steven B McMahon
International Journal of Molecular Sciences|October 23, 2021
Liquid Biopsies for Molecular Biology-Based RadiotherapyErik S Blomain, Everett J Moding
Cancer Biology & Therapy|April 23, 2016
GUCY2C ligand replacement to prevent colorectal cancerErik S Blomain, Amanda M Pattison, Scott A Waldman
Pigment Cell & Melanoma Research|March 16, 2013
Selective RAF inhibitor impairs ERK1/2 phosphorylation and growth in mutant NRAS, vemurafenib-resistant melanoma cellsKaitlyn Le, Erik S Blomain, Ulrich Rodeck, et al.
Expert Opinion on Drug Discovery|April 30, 2013
New advances in models and strategies for developing anti-obesity drugsGilbert W Kim, Jieru E Lin, Erik S Blomain, et al.
World Journal of Gastroenterology|October 1, 2016
Guanylyl cyclase C signaling axis and colon cancer preventionAmanda M Pattison, Dante J Merlino, Erik S Blomain, et al.
Journal of Clinical Medicine|August 4, 2015
Gut-Brain Endocrine Axes in Weight Regulation and Obesity PharmacotherapyDante J Merlino, Erik S Blomain, Amanda S Aing, et al.
Practical Radiation Oncology|August 16, 2020
A Preliminary Report of Gonadal-Sparing TBI Using a VMAT TechniqueErik S Blomain, Nataliya Kovalchuk, Beth K Neilsen, et al.
Molecular Pharmacology|June 3, 2016
Guanylyl Cyclase C Hormone Axis at the Intersection of Obesity and Colorectal CancerErik S Blomain, Dante J Merlino, Amanda M Pattison, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2CMatthew Witek, Erik S Blomain, Michael S Magee, et al.
Pageof 3